Donggu Biopharmaceutical
KOSDAQ · Healthcare · 998억원
₩3,680+3.95%
Price
5250.0원
3680.0원
Apr 27, 26Jul 22, 26
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue₩58.1B-6.2%
Operating Income₩1.8B-35.3%
Net Income-₩578MTurned to loss
12/'25 vs prev quarter
Company Health
Operating Margin+3.6%
PSR0.4x
PER2.0x
Short Volume4.2%as of 26.07.22
